Telaprevir D4
| Product Name | Telaprevir D4 |
|---|---|
| Alternate Names | Telaprevir Stable Isotopes, Stable Isotopes of Telaprevir |
| CAT No. | CS-O-03119 |
| CAS No. | 402957-28-2(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 679.84 g/mol |
| Mol. For. | C36H49D4N7O6 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Telaprevir |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C([C@@H]1[C@](CCC2)([H])[C@]2([H])CN1C([C@H](C(C)(C)C)NC([C@H](C3CCCCC3)NC(C4=NC=CN=C4)=O)=O)=O)N[C@@H](CCC)C(C(NC5C([2H])([2H])C5([2H])[2H])=O)=O |
| Canonical Smiles | CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5 |
| InchIKey | BBAWEDCPNXPBQM-GDEBMMAJSA-N |
| Inchl | InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1 |
| IUPAC | (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Telaprevir D4 is a deuterated form of Telaprevir, a drug used in the treatment of chronic hepatitis C virus (HCV) infection. The deuterated form of the drug is used for pharmacokinetic studies and investigations. The drug works by inhibiting the viral protease enzyme, which is essential for the replication of the virus.
Telaprevir D4 is administered orally, usually in combination with other drugs, in the form of a tablet. The recommended dosage is 750 mg three times a day, taken with food. The drug has a half-life of approximately 4 hours and is metabolized in the liver.
Chemically, Telaprevir D4 is a deuterated form of the parent drug Telaprevir. The deuterated form is created by replacing hydrogen atoms with deuterium atoms, which are stable isotopes of hydrogen. This modification alters the pharmacokinetics of the drug, resulting in slower clearance from the body, which may lead to improved efficacy and tolerability.
Clinical studies have shown that the use of Telaprevir D4 results in a reduction in the viral load in patients with chronic HCV infection. The drug has also been found to be well-tolerated, with minor side effects such as fatigue and headache.
In conclusion, Telaprevir D4 is an important tool for investigating the pharmacokinetics and efficacy of Telaprevir in the treatment of chronic HCV infection. It is a safe and effective drug that has the potential to improve the lives of millions of people suffering from this disease.
Get an Instant Quote
This page contains information about Telaprevir D4. You can buy Telaprevir D4 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Telaprevir D4